Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-21-060022

CHIEF EXECUTIVE OFFICER gave up 31,677 shares (to pay taxes)

  • CHIEF EXECUTIVE OFFICER acquired 75,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER 2021-09-30 Option exercise +75,000 130,377 D
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER 2021-09-30 Shares withheld for taxes −31,677 $14.57 $461,534 98,700 D
Derivatives
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER 2021-09-30 Option exercise · Restricted Stock Units −75,000 75,000 D
Loading xslF345X03/doc4.xml…